Review Note

Last Update: 04/17/2023 11:49 PM

Current Deck: IM ANKI::Infectious Diseases

Published

Currently Published Content

Text

Empiric outpatient therapy for PID: {{c1::Ceftriaxone 500 mg IM x1::dose and duration}} + {{c1::Doxycycline 100 mg q12h x14d::dose and duration}} to cover {{c2::Gonorrhea}}, {{c2::Chlamydia}}, and {{c2::anaerobic}} organisms.

Pt should have follow up in {{c1::3 days::time}} for repeat evaluation

Notes

Ceftriaxone was increased from 250 to 500 due to resistances building per CDC STI guidelines

Mnemonic

Clarifying Notes

Current Tags:

Empiric ID::Bacteria::GNC::Neisseria::gonorrhea ID::Chlamydia

Pending Suggestions

No pending suggestions for this note.